Close Menu

MLC Dx

Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.

People in the News: Sep 3, 2010

Premium

Norrie Russell, Thomas Willis, Malek Faham

Company executives have a patent pending that describes methods “for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions,” according to the recently published patent application.

Paired Ends: Aug 24, 2010

Premium

Thomas Willis, Malek Faham, Lawrence Tabak

The molecular diagnostics firm currently has a patent application for a method of using DNA sequencing technology for identifying biomarkers of autoimmune disease.

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.